Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Metabolic screening p-hydroxyl phenylalanine urine detection reagent

A technology for hydroxyphenylalanine and detection reagents is applied in the field of metabolic screening p-hydroxyphenylalanine urine detection reagents, which can solve the problems of reducing detection accuracy, limiting application value, false positives and the like, achieving easy judgment, The effect of high coincidence rate and short time

Inactive Publication Date: 2017-12-19
格朗生物技术(上海)有限公司
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the current urine metabolite detection reagents are highly sensitive, false positives often occur, which greatly reduces the accuracy of detection, causes misdiagnosis, and limits its application value

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A metabolite screening p-hydroxyphenylalanine urine detection reagent, which is composed of 0.10g / ml mercury sulfate aqueous solution, 0.55g / ml mercury nitrate aqueous solution, 0.12g / ml nickel nitrate aqueous solution and 1.20g / ml The selenous acid aqueous solution is mixed, and by volume ratio, mercuric sulfate aqueous solution: mercury nitrate aqueous solution: nickel nitrate aqueous solution: selenous acid aqueous solution=1: 0.8: 1.3: 0.6.

Embodiment 2

[0019] A metabolic screening p-hydroxyphenylalanine urine detection reagent, which is composed of 0.15g / ml mercury sulfate aqueous solution, 0.5g / ml mercury nitrate aqueous solution, 0.2g / ml nickel nitrate aqueous solution and 1g / ml The selenous acid aqueous solution is mixed, and in volume ratio, mercury sulfate aqueous solution: mercury nitrate aqueous solution: nickel nitrate aqueous solution: selenous acid aqueous solution=1: 1.2: 0.8: 1.0.

Embodiment 3

[0021] A metabolic screening p-hydroxyphenylalanine urine detection reagent, which is composed of 0.1g / ml mercury sulfate aqueous solution, 0.8g / ml mercury nitrate aqueous solution, 0.15g / ml nickel nitrate aqueous solution and 1.2g / ml The selenous acid aqueous solution is mixed, and by volume ratio, mercuric sulfate aqueous solution: mercury nitrate aqueous solution: nickel nitrate aqueous solution: selenous acid aqueous solution=1: 0.9: 0.8: 0.8.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a metabolic screening p-hydroxyl phenylalanine urine detection reagent, which is formed by mixing a 0.1-0.15 g / ml mercury sulfate aqueous solution, a 0.5-1 g / ml mercury nitrate aqueous solution, a 0.1-0.2 g / ml nickel nitrate aqueous solution and a 1-2 g / ml selenous acid aqueous solution according to a volume ratio of 1:0.6-1.2:0.8-1.5:0.5-1.0. According to the present invention, the detection reagent has characteristics of strong universality, high sensitivity, good specificity and the like in tumor detection, further has advantages of simple detection process, short detection time and easy result judgment, and is particularly suitable for the large-scale population census and the tumor clinical auxiliary diagnosis and treatment effect dynamic examination.

Description

technical field [0001] The invention belongs to urine detection reagents, in particular to a urine detection reagent for metabolic screening p-hydroxyphenylalanine. Background technique [0002] Early diagnosis and early treatment of tumors are the key to improving the cure rate of tumors. The commonly used diagnostic methods in clinical practice include chest X-ray, B-ultrasound, CT, and nuclear magnetic resonance, etc., which are often accompanied by puncture, blood drawing, etc., which aggravate the pain of the patient and may even cause cross-infection, and are expensive. More importantly, through these The tumors that can be detected by means are generally in the middle and late stage, which brings great pain and economic burden to the patients. Therefore, it is imperative to develop a detection method with simple and quick operation, low cost, high sensitivity and good repeatability. [0003] Abnormal nucleotide metabolism of tumor cells produces a monohydric phenoli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/574
CPCG01N33/574G01N33/57484G01N2800/7028
Inventor 魏谦
Owner 格朗生物技术(上海)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products